Navigation Links
Cantel Medical Corp. to Present at the Oppenheimer & Co. 19th Annual Healthcare Conference
Date:10/29/2008

LITTLE FALLS, N.J., Oct. 29 /PRNewswire-FirstCall/ -- CANTEL MEDICAL CORP. (NYSE: CMN) announced today that Andrew A. Krakauer, President, will be presenting at the Oppenheimer & Co. Inc. 19th Annual Healthcare Conference. The presentation is scheduled for 10:00 AM ET on Monday, November 3, 2008 at the Waldorf-Astoria in New York City. The presentation will be available on the Investor Relations section of the company's website: http://www.cantelmedical.com.

Cantel Medical Corp. is a leading provider of infection prevention and control products in the healthcare market. Our products include specialized medical device reprocessing systems for renal dialysis and endoscopy, dialysate concentrates and other dialysis supplies, disposable infection control products primarily for the dental industry, water purification equipment, sterilants, disinfectants and cleaners, hollow fiber membrane filtration and separation products for medical and non-medical applications, and specialty packaging for infectious and biological specimens. We also provide technical maintenance for our products and offer compliance training services for the transport of infectious and biological specimens.


'/>"/>
SOURCE Cantel Medical Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related medicine news :

1. Cantel Medical to Relocate Dutch Manufacturing Operations to the United States to Achieve Operating Savings
2. Cantel Medical Corp. and National Safety Council Launch Joint Initiative to Prepare Businesses and Individuals for Flu Pandemic
3. Lazarex Cancer Foundation Sponsors Community Colorectal Cancer Screening at Alta Bates Summit Medical Center
4. China Medical Technologies to Attend Credit Suisse Asian Healthcare Conference
5. ATS Medical Announces Third Quarter 2008 Earnings Release Date and Conference Call
6. Rochester Medical Announces Fourth Quarter 2008 Earnings Conference Call November 6, 2008
7. China Sky One Medical, Inc. Acquires Drug to Treat Breast Lesions
8. Response Biomedical Completes Initial Closing of an expected $5.0 Million Financing
9. Medical Reimbursement Consultants, Inc. Selects LeonardoMD for Web-based Medical Billing
10. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
11. Top Indian Cancer Hospital to Introduce Advanced Radiosurgery Treatments With Novalis Tx from Varian Medical Systems and BrainLAB

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...rug tetrathiomolybdate (TM) has been shown in stud...ease, a disease caused by an overload of copper, a... Very little, however, is known about how the drug... by Northwestern University researchers now has pr...tructure of TM bound to copper-loaded metallochape...
(Date:11/26/2009)...en on an emotional rollercoaster, study finds , ...ll it the fear factor meets the jubilant sports fa...pecially those who root for the winning team -- en...ntested match and victory was in doubt, producing ...hat this Thanksgiving weekend as you,re glued to t...
(Date:11/26/2009)...r. David Kim of the Live Life Again Center, a prac...one of a growing number of physicians who are tak...o connect with individuals who are interested in s...ity. Dr. Kim is utilizing Facebook to share before...ce with the community. , ...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
(Date:11/25/2009)...ov. 25 When most people.... But a chiropractor can also give patients the h...lar Joint, which is where your jaw (mandible) cont..., The most common symptoms associated with TMJ d...ing of the jaw. But many other symptoms can be ca...
Breaking Medicine News(10 mins):Health News:Research sheds light on workings of anti-cancer drug 2Health News:Research sheds light on workings of anti-cancer drug 3Health News:Watching the Nail-Biting Big Game Hurts So Good 2Health News:Watching the Nail-Biting Big Game Hurts So Good 3Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Pharmacist Injects Cure for Ailing Businesses 2
...LLERTON, Calif., Dec. 4 Beckman Coulter,Inc. (NYS...marketer of,products that simplify, automate, and ...y that Scott Garrett, Beckman Coulter,s president ...(Logo: http://www.newscom.com/cgi-bin/prnh/200312...
...W YORK, Dec. 4 The holidays are all about bringin...er one roof, it also means,a lot more bacteria. Ho...e,and the potential for more bacteria in common ar...., , Listen to this report from Philips at:, http...
...nancing Provides Capital to Complete EVEREST Pivot...Commercialization Company Provides Updated..., Dec. 4 Evalve, Inc., the leader in,the developm...Fund LP led the round and was joined by investors ...
...ople in good shape tend to outlive folks who aren,...Day News) -- In the quest for a longer life, a new...u,re fat. , Overweight and obese seniors who were ...rong determinate of mortality in older men and wom...
... measures nervous system and heart,s electrical sy...-- A test of two heart functions accurately spotte...ath as they recovered from a heart attack, Canadia...uthor Dr. Derek V. Exner, associate professor of m...
...CKVILLE, Md., Dec. 4 Nabi,Biopharmaceuticals (Nas... the,sale of assets constituting its Biologics str...als Corporation, a wholly-owned subsidiary of Biot...ts,including Nabi- HB(R) and other plasma business...
Other Medicine News:Health News:UPDATED: Evalve(R) Completes $60 Million Series D Financing 2Health News:UPDATED: Evalve(R) Completes $60 Million Series D Financing 3Health News:Fitness, Not Fatness, Predicts a Longer Life 2Health News:2-in-1 Test Signals Risk After Heart Attack 2Health News:2-in-1 Test Signals Risk After Heart Attack 3Health News:Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG 2Health News:Nabi Biopharmaceuticals Completes Sale of Nabi Biologics to Biotest AG 3
(Date:11/25/2009)... , SAN DIEGO, Nov. 25 /PRNewswire-FirstCall...vice company focused on developing products for mi...ne, announced today that it will host a conference...T / 2:30 p.m. PT. The conference call will focus ...e Company,s products and will include comments fro...
(Date:11/25/2009)..., FRAMINGHAM, Mass. and SYDNEY, Nov. 25 /PRNewsw...asdaq: HTWR ; ASX: HIN), a leading innovator and ...y support technologies revolutionizing the treatme... it is scheduled to make an investor presentation ...rence at 8:00 am EST on Wednesday, December 2, 200...
(Date:11/24/2009)..., MADISON, N.J., Nov. 24 /PRNewswire-FirstCall/... the world,s leading provider of diagnostic testin...scheduled to speak at the 21st Annual Piper Jaffra...sentation is scheduled for Wednesday, December 2, ...onference, the company will reaffirm its 2009 guid...
Breaking Medicine Technology:NuVasive Announces Conference Call and Webcast Regarding Reimbursement 2NuVasive Announces Conference Call and Webcast Regarding Reimbursement 3NuVasive Announces Conference Call and Webcast Regarding Reimbursement 4HeartWare to Present at 21st Annual Piper Jaffray Health Care Conference in New York City 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2Bycatch whaling a growing threat to coastal whales 8973 1Bycatch whaling a growing threat to coastal whales 8973 2ADHD Genes Found 3B Known to Play Roles in Neurodevelopment 4634 1ADHD Genes Found 3B Known to Play Roles in Neurodevelopment 4634 2ADHD Genes Found 3B Known to Play Roles in Neurodevelopment 4634 3ADHD Genes Found 3B Known to Play Roles in Neurodevelopment 4634 4Experimental Urine Test Spots Appendicitis 49786 1Experimental Urine Test Spots Appendicitis 49786 2
...ticals,Inc., a privately held biopharmaceutical co...d today that the U.S. Food and Drug,Administration...anted A-001,orphan drug status for the prevention ...ll disease., A-001 is currently being evaluated f...al in the United States called IMPACTS (Investigat...
...n,(Nasdaq: DRRX ) announced today positive result...DURECT,s proprietary investigational transdermal p...m post-herpetic neuralgia,ELADUR showed improved p...uous treatment period. In addition, ELADUR appeare...h ELADUR and placebo exhibited similar,safety prof...
Other Medicine Technology:Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 2Anthera's A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease 3DURECT Announces Positive ELADUR(TM) Phase IIa Study Results 2DURECT Announces Positive ELADUR(TM) Phase IIa Study Results 3
External Ventricular Drainage (EVD)
Bactiseal EVD Catheter
Monitorr ICP External CSF Drainage and Monitoring System
Sodem Skull Perforator Motor
Medicine Products: